Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome

European Journal of Pediatrics

Volumn 163, Issue 7, 2004, Pages 374-377

  Dormann, Sabine ^a   Krüger, Marcos ^a   Hentschel, Roland ^a   Rasenack, Regina ^a   Strahm, Brigitte ^a   Kontny, Udo ^a   Niemeyer, Charlotte ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Complications; Down syndrome; Hydrops; Intensive care; Transient abnormal myelopoiesis

Indexed keywords

ANTILEUKEMIC AGENT; CYTARABINE; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; AMNIOCENTESIS; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; ASCITES; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DOWN SYNDROME; FEMALE; FETUS DISTRESS; FETUS HYDROPS; HEMATOLOGIC DISEASE; HEPATOMEGALY; HUMAN; HYDRAMNIOS; LUNG HYPOPLASIA; MALE; MORTALITY; NEWBORN; PERICARDIAL EFFUSION; PLACENTA PREVIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SURVIVAL RATE; TRANSIENT ABNORMAL MYELOPOIESIS; TRISOMY 21;

BLOOD CELL COUNT; BLOOD CELLS; CYTARABINE; DOWN SYNDROME; FEMALE; HEMATOLOGIC DISEASES; HUMANS; HYDROPS FETALIS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; LIVER CIRRHOSIS; MALE; MYELOPOIESIS; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 3142683137     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-004-1452-7     Document Type: Article

References (17)

1. Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P (2004) Natural history of GATA 1 mutations in Down syndrome. Blood 103: 2480-2489
2. Al-Kasim F, Doyle JJ, Massey GV, Weinstein HJ, Zipursky A (2002) Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol 24: 9-13
3. Avet-Loiseau H, Mechinaud F, Harousseau JL (1995) Clonal hematologic disorders in Down syndrome. J Pediatr Hematol Oncol 17: 19-24
4. Bonno M, Azuma E, Kawasaki H, Zhang ZL, Komada Y, Hirayama M, Higashiwaga M, Umemoto M, Umemoto M, Koike T, Kato T, Tahara T, Miyazaki H, Sakurai M (1998) Thrombopoietin level is inversely related to blast count, not platelet number, in Down syndrome neonates with transient myeloproliferative disorder. Am J Hematol 58: 267-272
5. Coulombel L, Derycke M, Villeval JL, Leonard C, Breton-Gorius J, Vial M, Bourgeois P, Tchernia G (1987) Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder. Br J Haematol 66: 69-76
6. Creutzig U, Ritter J, Vormoor J, Eschenbach C, Dickerhoff R, Burdach S, Scheel-Walter HG, Kühl J, Schellong G (1990) Transient myeloproliferation and acute myeloid leukemia in infants with Down's syndrome. Klin Pädiatr 202: 253-257
7. Garel D, Mielot F, Gaulard P, Quillard J, Doomergues JP, Tchernia G (1991) Acute megakaryocytic leukaemia (AMKL) with major myelofibrosis in an infant. Diagnosis by liver biopsy and response to treatment. Nouv Rev Fr Hematol 33: 5-8
8. Hirashima C, Eguchi Y, Kohumara Y, Minatami H, Sato I (2000) Isolated pericardial effusion and transient abnormal myelopoiesis in a fetus with Down's syndrome. J Obstet Gynaecol Res 26: 303-306
9. Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A (2003) GATA 1 mutations in transient leukemia and acute megakaryoblastic leukemia in Down syndrome. Blood 101: 4301-4304
10. Homans AC, Verissimo AM, Vlacha V (1993) Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol 15: 392-399
11. Schwab M, Niemeyer CM, Schwarzer U (1998) Down syndrome, transient myeloproliferative disorder and infantile liver fibrosis. Med Pediatr Oncol 31: 159-165
12. Tchernia G, Lejeune F, Boccara JF, Denavit MF, Dommergues JP, Bernaudin F (1996) Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine. J Pediatr Hematol Oncol 18: 59-62
13. Yagihashi N, Watanabe K, Yagihashi S (1995) Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome. J Clin Pathol 48: 973-975
14. Yoshioka K, Yamamoto S, Moriguchi N, Miyata H, Tsukiyama K, Isokawa S, Horiuchi F, Takemura T (2000) Overexpression of bcl-2 in transient abnormal myelopoiesis associated with Down syndrome. Ann Hematol 79: 319-321
15. Zipursky A (1996) The treatment of children with acute megakaryoblastic leukaemia who have Down syndrome. Pediatr Hematol Oncol 18: 10-12
16. Zipursky A, Poon A, Doyle J (1992) Leukemia in Down syndrome: a review. Pediatr Hematol Oncol 9: 139-149
17. Zipursky A, Brown EJ, Christensen H, Doyle J (1999) Transient myeloproliferative disorder (transient leukemia) and the hematologic manifestations of Down syndrome. Clin Lab Med 19: 157-167